NCT02255799View on ClinicalTrials.gov

Multicenter Evaluation of Memory Remediation After TBI With Donepezil

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

December 4, 2024

Study Completion Date

December 4, 2024

Conditions
Traumatic Brain InjuryMemory Deficits
Interventions
DRUG

Donepezil

Donepezil 5 mg capsule daily for 14 days. Donepezil 10 mg capsule daily for 56 days.

DRUG

Placebo

Placebo capsule once daily for 70 days.

Trial Locations (4)

19027

Moss Rehabilitation Research Institute, Elkins Park

46202

Indiana University, Indianapolis

77030

TIRR Memorial Hermann, Houston

02129

Spaulding Rehabilitation Hospital, Charlestown

All Listed Sponsors
collaborator

Spaulding Rehabilitation Hospital

OTHER

collaborator

Albert Einstein Healthcare Network

OTHER

collaborator

Indiana University

OTHER

collaborator

Craig Hospital

OTHER

collaborator

TIRR Memorial Hermann

OTHER

lead

Baylor College of Medicine

OTHER

NCT02255799 - Multicenter Evaluation of Memory Remediation After TBI With Donepezil | Biotech Hunter | Biotech Hunter